Treatment of Hypercholesterolaemia in South Asian Subjects (IRIS)

PHASE3CompletedINTERVENTIONAL
Enrollment

2,340

Participants

Timeline

Start Date

October 31, 2002

Study Completion Date

March 31, 2005

Conditions
HypercholesterolemiaDyslipidaemia
Interventions
DRUG

Rosuvastatin

DRUG

Atorvastatin

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY